Search details
1.
Something old, something new: The marriage of PD-1 and IL-2.
Immunity
; 56(1): 8-10, 2023 01 10.
Article
in English
| MEDLINE | ID: mdl-36630920
2.
Tissue-specific abundance of interferon-gamma drives regulatory T cells to restrain DC1-mediated priming of cytotoxic T cells against lung cancer.
Immunity
; 56(2): 386-405.e10, 2023 02 14.
Article
in English
| MEDLINE | ID: mdl-36736322
3.
Type I interferon activates MHC class I-dressed CD11b+ conventional dendritic cells to promote protective anti-tumor CD8+ T cell immunity.
Immunity
; 55(2): 308-323.e9, 2022 02 08.
Article
in English
| MEDLINE | ID: mdl-34800368
4.
Increased demand for NAD+ relative to ATP drives aerobic glycolysis.
Mol Cell
; 81(4): 691-707.e6, 2021 02 18.
Article
in English
| MEDLINE | ID: mdl-33382985
5.
Deciphering the immunopeptidome in vivo reveals new tumour antigens.
Nature
; 607(7917): 149-155, 2022 07.
Article
in English
| MEDLINE | ID: mdl-35705813
6.
CD36 - the Achilles' heel of Treg cells.
Nat Immunol
; 21(3): 251-253, 2020 03.
Article
in English
| MEDLINE | ID: mdl-32066948
7.
A Tumor Cell-Intrinsic Yin-Yang Determining Immune Evasion.
Immunity
; 49(1): 11-13, 2018 07 17.
Article
in English
| MEDLINE | ID: mdl-30021140
8.
MHC-dressing on dendritic cells: Boosting anti-tumor immunity via unconventional tumor antigen presentation.
Semin Immunol
; 66: 101710, 2023 03.
Article
in English
| MEDLINE | ID: mdl-36640616
9.
Both intratumoral regulatory T cell depletion and CTLA-4 antagonism are required for maximum efficacy of anti-CTLA-4 antibodies.
Proc Natl Acad Sci U S A
; 120(31): e2300895120, 2023 08.
Article
in English
| MEDLINE | ID: mdl-37487077
10.
Alum-anchored intratumoral retention improves the tolerability and antitumor efficacy of type I interferon therapies.
Proc Natl Acad Sci U S A
; 119(36): e2205983119, 2022 09 06.
Article
in English
| MEDLINE | ID: mdl-36037341
11.
STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors.
Immunity
; 41(5): 830-42, 2014 Nov 20.
Article
in English
| MEDLINE | ID: mdl-25517615
12.
Melanoma-intrinsic ß-catenin signalling prevents anti-tumour immunity.
Nature
; 523(7559): 231-5, 2015 Jul 09.
Article
in English
| MEDLINE | ID: mdl-25970248
13.
Tumor Heterogeneity and Tumor Immunity: A Chicken-and-Egg Problem.
Trends Immunol
; 37(6): 349-351, 2016 06.
Article
in English
| MEDLINE | ID: mdl-27166403
14.
Density of immunogenic antigens does not explain the presence or absence of the T-cell-inflamed tumor microenvironment in melanoma.
Proc Natl Acad Sci U S A
; 113(48): E7759-E7768, 2016 11 29.
Article
in English
| MEDLINE | ID: mdl-27837020
15.
Cutting Edge: Engineering Active IKKß in T Cells Drives Tumor Rejection.
J Immunol
; 196(7): 2933-8, 2016 Apr 01.
Article
in English
| MEDLINE | ID: mdl-26903482
16.
Mechanisms of tumor escape in the context of the T-cell-inflamed and the non-T-cell-inflamed tumor microenvironment.
Int Immunol
; 28(8): 383-91, 2016 08.
Article
in English
| MEDLINE | ID: mdl-26989092
17.
Cancer Immunotherapy Targets Based on Understanding the T Cell-Inflamed Versus Non-T Cell-Inflamed Tumor Microenvironment.
Adv Exp Med Biol
; 1036: 19-31, 2017.
Article
in English
| MEDLINE | ID: mdl-29275462
18.
Future perspectives in melanoma research : Meeting report from the "Melanoma Bridge". Napoli, December 1st-4th 2015.
J Transl Med
; 14(1): 313, 2016 11 15.
Article
in English
| MEDLINE | ID: mdl-27846884
19.
TCR-transgenic lymphocytes specific for HMMR/Rhamm limit tumor outgrowth in vivo.
Blood
; 119(15): 3440-9, 2012 Apr 12.
Article
in English
| MEDLINE | ID: mdl-22371883
20.
A prime editor mouse to model a broad spectrum of somatic mutations in vivo.
Nat Biotechnol
; 42(3): 424-436, 2024 Mar.
Article
in English
| MEDLINE | ID: mdl-37169967